SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Boehringer Ingelheim Pharmaceuticals, Inc. Release: New Sub-Analyses Report Pradaxa® (Dabigatran Etexilate Mesylate) May be Associated With Better Patient Outcomes After a Major Bleeding Event Compared to Warfarin